Global Custom Market Research Reports Provider Company


Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The companys pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidates. Its immuno-oncology product candidates include adaptive NK, pluripotent cell-derived cancer immunotherapies, and engineered CAR and TCR T- cell immunotherapies. Its products are derived from pluripotent cells. Fate Therapeutics uses ex vivo cell programming approach to include cell-surface proteins, rapid and supra-physiologic activation or inhibition of therapeutically-relevant genes, and to regulate the therapeutic function. The companys immuno-regulatory cellular therapies promote immune system homeostasis for patients undergoing hematopoietic cell transplantation and immune disorders. Fate Therapeutics is headquartered in San Diego, California, the US.

Fate Therapeutics Inc Key Recent Developments

Nov 01,2017: Fate Therapeutics Reports Third Quarter 2017 Financial Results
Sep 14,2017: Fate Therapeutics Appoints Jim Beitel as Senior Vice President, Corporate Development
Aug 14,2017: Fate Therapeutics Reports Second Quarter 2017 Financial Results
May 15,2017: Fate Therapeutics Reports First Quarter 2017 Financial Results
Mar 16,2017: Fate Therapeutics Reports Fourth Quarter 2016 Financial Results

This comprehensive SWOT profile of Fate Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Fate Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents

Section 1 - About the Company

Fate Therapeutics Inc - Key Information

Fate Therapeutics Inc - Overview

Fate Therapeutics Inc - Key Employees

Fate Therapeutics Inc - Key Employee Biographies

Fate Therapeutics Inc - Key Operational Heads

Fate Therapeutics Inc - Major Products and Services

Fate Therapeutics Inc - History

Fate Therapeutics Inc - Company Statement

Fate Therapeutics Inc - Locations And Subsidiaries

Fate Therapeutics Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Fate Therapeutics Inc - Business Description

Fate Therapeutics Inc - Corporate Strategy

Fate Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Fate Therapeutics Inc - Strengths

Fate Therapeutics Inc - Weaknesses

Fate Therapeutics Inc - Opportunities

Fate Therapeutics Inc - Threats

Fate Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Fate Therapeutics Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

Fate Therapeutics Inc, Key Information

Fate Therapeutics Inc, Key Ratios

Fate Therapeutics Inc, Share Data

Fate Therapeutics Inc, Major Products and Services

Fate Therapeutics Inc, History

Fate Therapeutics Inc, Key Employees

Fate Therapeutics Inc, Key Employee Biographies

Fate Therapeutics Inc, Key Operational Heads

Fate Therapeutics Inc, Other Locations

Fate Therapeutics Inc, Subsidiaries

Fate Therapeutics Inc, Key Manufacturing facilities

Fate Therapeutics Inc, Key Competitors

Fate Therapeutics Inc, SWOT Analysis

Fate Therapeutics Inc, Ratios based on current share price

Fate Therapeutics Inc, Annual Ratios

Fate Therapeutics Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures

Fate Therapeutics Inc, Performance Chart

Fate Therapeutics Inc, Ratio Charts

Cobalt Sulfate Cobalt sulphate is an inorganic chemical that is available in the form of a reddish, metallic salt. It is toxic and soluble in water and other organic solvents.

View Report

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC - Pipeline Review, H1 2018 Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or

View Report

The global market size of Behentrimonium Methosulfate is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports